Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Santeusanio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetes Spectrum : a Publication of the American Diabetes Association|August 25, 2018
Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial InsulinAndrew D Santeusanio, Monica M Bowen
Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. <i>Diabetes Spectrum</i> 2018;31:261-266 (doi.org/10.2337/ds17-0068)Andrew D Santeusanio, Monica M Bowen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 10, 2017
Antiviral treatment of BK virus viremia after kidney transplantationAndrew D Santeusanio, Benjamin E Lukens, Judy Eun
Progress in Transplantation (Aliso Viejo, Calif.)|September 17, 2022
Comparison of Intensive Insulin Versus Oral Regimens on Early Glycemic Control Following Kidney TransplantAdina Petrosan, Andrew D Santeusanio, Rafael Khaim, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 8, 2019
Is There a Role for Desensitization in Intestinal Transplantation?Andrew D Santeusanio, Jang Moon, Vinay Nair, et al.
Journal of Pharmacy Practice|November 3, 2017
The Impact of Cirrhosis and Prescription Medications on QTc Interval Before and After Liver TransplantationAndrew D Santeusanio, Kevin G Dunsky, Stephanie Pan, et al.
Clinical Transplantation|November 19, 2019
Safety of direct-acting oral anticoagulants relative to warfarin in a matched cohort of liver transplant recipientsAndrew D Santeusanio, Alan D Weinberg, Sander S Florman, et al.
Clinical Transplantation|March 19, 2021
Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantationAndrew D Santeusanio, Alan Gu, Alan D Weinberg, et al.
Clinical Transplantation|January 30, 2024
Risk factors for renal dysfunction after isolated intestinal transplantationDagny von Ahrens, Andrew D Santeusanio, Alan D Weinberg, et al.
Clinical Transplantation|February 13, 2020
Conversion to belatacept within 1-year of renal transplantation in a diverse cohort including patients with donor-specific antibodiesAndrew D Santeusanio, Arjun Bhansali, Alan Weinberg, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes Spectrum : a Publication of the American Diabetes Association|August 25, 2018
Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial InsulinAndrew D Santeusanio, Monica M Bowen
Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. <i>Diabetes Spectrum</i> 2018;31:261-266 (doi.org/10.2337/ds17-0068)Andrew D Santeusanio, Monica M Bowen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 10, 2017
Antiviral treatment of BK virus viremia after kidney transplantationAndrew D Santeusanio, Benjamin E Lukens, Judy Eun
Progress in Transplantation (Aliso Viejo, Calif.)|September 17, 2022
Comparison of Intensive Insulin Versus Oral Regimens on Early Glycemic Control Following Kidney TransplantAdina Petrosan, Andrew D Santeusanio, Rafael Khaim, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 8, 2019
Is There a Role for Desensitization in Intestinal Transplantation?Andrew D Santeusanio, Jang Moon, Vinay Nair, et al.
Journal of Pharmacy Practice|November 3, 2017
The Impact of Cirrhosis and Prescription Medications on QTc Interval Before and After Liver TransplantationAndrew D Santeusanio, Kevin G Dunsky, Stephanie Pan, et al.
Clinical Transplantation|November 19, 2019
Safety of direct-acting oral anticoagulants relative to warfarin in a matched cohort of liver transplant recipientsAndrew D Santeusanio, Alan D Weinberg, Sander S Florman, et al.
Clinical Transplantation|March 19, 2021
Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantationAndrew D Santeusanio, Alan Gu, Alan D Weinberg, et al.
Clinical Transplantation|January 30, 2024
Risk factors for renal dysfunction after isolated intestinal transplantationDagny von Ahrens, Andrew D Santeusanio, Alan D Weinberg, et al.
Clinical Transplantation|February 13, 2020
Conversion to belatacept within 1-year of renal transplantation in a diverse cohort including patients with donor-specific antibodiesAndrew D Santeusanio, Arjun Bhansali, Alan Weinberg, et al.
Pageof 2